Riskpilot← Back to searchSign inGet full accessCellevate AB
ABActiveOrg 5569648438Scheelevägen 8 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 201410-19 employees
Revenue 2024
SEK 62K
-79% vs 2023
EBITDA margin
-34696.8%
-168% vs 2023
Equity ratio
82.6%
Financial strength
Net profit 2024
SEK -21,4M
-163% vs 2023
| Revenue | SEK 62K | -79% |
| EBITDA | SEK -21,5M | -168% |
| Net profit | SEK -21,4M | -163% |
| Total assets | SEK 56,4M | +18% |
| Equity | SEK 46,5M | +49% |
| Employees | — | — |
Legal name
Cellevate AB
Org number
5569648438
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 mars 2014
Share capital
SEK 167 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska arbeta med utveckling av produktionsmetoder för tillverkning av mikro- och nanofiber, samt utveckling, kommersia- lisering och försäljning av produkter baserade på mikro- och nanofiber primärt men inte uteslutande inom life-science.
Address
Scheelevägen 8 B
Phone
+46736333390
Email
maximilian.ottosson@cellevate.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 113 | 147 | 115 | 641 | 378 | 317 | 290 | 62 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −133 | −452 | −527 | −551 | −3 546 | −1 825 | −2 518 | −7 426 | −8 040 | −21 512 |
| Depreciation & amort. | −0 | −0 | −0 | −24 | −24 | −24 | −169 | −303 | −439 | −793 |
| EBIT | −133 | −452 | −527 | −575 | −3 570 | −1 849 | −2 687 | −7 729 | −8 479 | −22 305 |
| Net financials | −1 | — | — | — | −1 | −1 | −1 | 292 | 341 | 889 |
| Profit before tax | −134 | −419 | −526 | −575 | −3 571 | −1 849 | −2 688 | −7 437 | −8 138 | −21 416 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −134 | −419 | −526 | −575 | −3 571 | −1 849 | −2 688 | −7 437 | −8 138 | −21 416 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 75 | 1 877 | 1 385 | 5 813 | 2 274 | 4 518 | 7 553 | 15 558 | 47 645 | 56 364 |
| Equity | −6 | 1 773 | 1 249 | 5 674 | 2 103 | 4 199 | 5 792 | 3 829 | 31 252 | 46 537 |
| Long-term debt | 0 | 62 | 62 | 62 | 62 | 62 | 0 | 0 | 0 | 0 |
| Short-term debt | 48 | 42 | 74 | 76 | 109 | 256 | 1 760 | 11 729 | 16 393 | 9 827 |
| Total debt | 48 | 104 | 136 | 138 | 171 | 318 | 1 760 | 11 729 | 16 393 | 9 827 |
EBITDA margin
-34696.8%
This company
15.8%
Market median
-219700% vs market
20152024
Equity ratio
82.6%
This company
38.2%
Market median
+116% vs market
20152024
Return on equity
-46.0%
This company
18.4%
Market median
-350% vs market
20152024
Net profit margin
-34541.9%
This company
8.1%
Market median
-426543% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ML | Audit | 2022 | — | — |
LC Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2021 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Cellevate AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats-Åke Lennart Andersson | Audit | 0 companies |
| Laura Cristina Chirica | Chief Executive Officer | 0 companies |
| Maximilian Christian Ottosson | Board of Directors | 0 companies |
| Sankhamala Valroy | Board of Directors | 0 companies |
| Mats Peter Egon Grahn | Board of Directors | 0 companies |
| Bertil Erik Lindmark | Board of Directors | 0 companies |
| Peter Paresh Jhaveri | Chairman | 0 companies |
| Bettina Erika Berendsen | Board of Directors | 0 companies |
| Uwe Gottschalk | Chairman | 0 companies |
| Sara Kristina Frykstrand Ångström | Board of Directors | 0 companies |
| Ulf Peter Thulin | Chairman | 0 companies |
| Johan Erik Fredstorp | Board of Directors | 0 companies |
| Karl Håkan Tobias Ekman | Board of Directors | 0 companies |
| Mats Olof Leifland | Chairman | 0 companies |